EconTalk cover image

Richard Epstein on Property Rights and Drug Patents

EconTalk

00:00

Why pharma pays to speed FDA review

Epstein cites PDUFA fees as evidence firms prefer faster approvals, undermining anti-competitive regulatory motives.

Play episode from 56:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app